These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11387363)

  • 1. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
    Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
    J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid switching from morphine to methadone in cancer patients with poor response to morphine.
    Mercadante S; Casuccio A; Calderone L
    J Clin Oncol; 1999 Oct; 17(10):3307-12. PubMed ID: 10506634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
    Tse DM; Sham MM; Ng DK; Ma HM
    Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
    Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
    Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of methadone in opioid rotation-a Polish experience.
    Leppert W
    Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study.
    Cubero DI; del Giglio A
    Support Care Cancer; 2010 Feb; 18(2):235-42. PubMed ID: 19421788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
    Moryl N; Kogan M; Comfort C; Obbens E
    Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study.
    Fredheim OM; Kaasa S; Dale O; Klepstad P; Landrø NI; Borchgrevink PC
    Palliat Med; 2006 Jan; 20(1):35-41. PubMed ID: 16482756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.